GastroAGI Logo
OverviewBlogsAbout
Trending TopicsDaily BriefConference
Topics/Endoscopy/Digital Family History Assessment Improves CRC Risk Stratification in Endoscopy | Endoscopy
44

Digital Family History Assessment Improves CRC Risk Stratification in Endoscopy | Endoscopy

Clinical knowledge base written and curated by GastroAGI Team from primary medical literatureLast updated April 1, 2026

Introduction

Family history remains a critical but underused tool in colorectal cancer (CRC) risk assessment. Despite its importance in identifying individuals at increased hereditary risk, family history is often incompletely captured in routine endoscopy practice, leading to missed opportunities for genetic referral, inappropriate surveillance and inefficient colonoscopy use.

Problem Statement

Conventional family history assessment in endoscopy services is inconsistent, time-intensive and frequently insufficient for accurate CRC risk stratification. This creates two major clinical problems: overuse of colonoscopic surveillance in low-risk individuals and under-recognition of patients who may warrant enhanced surveillance or genetic evaluation. A practical, scalable approach is needed to integrate standardized hereditary risk assessment into routine endoscopy workflows.

Summary

This service improvement project demonstrates that integrating a digital family history questionnaire with a dedicated endoscopy genetic counsellor can substantially improve CRC risk stratification and surveillance efficiency within a modern endoscopy unit. In patients already undergoing family history–based surveillance, standardized reassessment led to clinically meaningful changes in surveillance recommendations for most patients, predominantly by downgrading unnecessary colonoscopy intensity, resulting in major reductions in avoidable procedures and substantial cost savings. In symptomatic patients, the same digital pathway identified previously unrecognized familial CRC risk, including individuals warranting moderate- or high-risk surveillance and potential genetic evaluation. These findings show that embedding structured family history assessment into routine endoscopy is both feasible and clinically impactful, improving risk stratification while optimizing resource utilization. The model is particularly valuable because it simultaneously reduces over-surveillance in low-risk patients and improves detection of individuals with clinically relevant inherited CRC risk. This scalable approach offers a practical framework for integrating precision prevention and genetic triage into everyday endoscopy practice.

Related Q&A

45

Single-Dose NSAIDs in ERCP: Gastroenterology | May 2026

Introduction Post-ERCP pancreatitis (PEP) remains one of the most common and serious complications of Endoscopic Retrograde Cholangiopancreatography. Rectal NSAIDs such as Indomethacin and Diclofenac are strongly recommended for...

46

OTSC vs Band Ligation in Diverticular Bleeding: GIE | April 2026

Introduction Colonic diverticular bleeding is an increasingly common cause of lower gastrointestinal bleeding, particularly with aging populations. Although many cases resolve spontaneously, recurrent or severe bleeding often requires...

47

GLP-1 Therapy vs Bariatric Endoscopy: Obesity Surgery | April 2026

Introduction The management of obesity and type 2 diabetes has rapidly evolved, with GLP-1 receptor agonists emerging as highly effective pharmacological options, while bariatric endoscopic therapies provide minimally...

48

Should We Continue Colonoscopy surveillance After 75?: JAMA | April 2026

Introduction Colorectal cancer (CRC) screening and surveillance have significantly reduced cancer-related mortality. However, in adults aged ≥75 years, clinical decision-making becomes complex. While cancer risk increases with age,...

49

BSG Interim Position on LAMS Use After AXIOS Recall: FG | April 2026

Introduction Lumen-apposing metal stents (LAMS) have become central to therapeutic endoscopic ultrasound (T-EUS), especially for pancreatic fluid collection drainage, EUS-guided gallbladder drainage, choledochoduodenostomy, gastrojejunostomy, and EDGE procedures. In...

50

AI in Colonoscopy Withdrawal Time Accuracy: Endoscopy | April 2026

Introduction Withdrawal time during colonoscopy is a key quality indicator directly linked to adenoma detection and colorectal cancer prevention. However, accurate measurement in routine practice is often inconsistent,...

GastroAGI Logo

We are pioneers in clinical intelligence, dedicated to helping gastroenterologists harness the power of artificial intelligence to drive precision, efficiency, and patient growth.

For You

For StudentsFor CliniciansFor ResearchersSoonFor Patients

Core Tools

MELD-Na ScoreChild-PughFIB-4 IndexGlasgow-BlatchfordBISAP Score

Explore

OverviewAboutCalculators
Trending Topics
Conference Briefings
Blog Insights
©GastroAGI 2026
Privacy PolicyTerms of UseMedical Disclaimer